Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PHARMACEUTICALS

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

ROSUVASTATIN FOR SYSTEM SUITABILITY CRS (15 MG)

ROSUVASTATIN FOR SYSTEM SUITABILITY CRS (15 MG)

147098-20-2

DISCOVER
ROSUVASTATIN IMPURITY G CRS (0.004 MG)

ROSUVASTATIN IMPURITY G CRS (0.004 MG)

1242184-42-4

DISCOVER
TRICLABENDAZOLE FOR SYSTEM SUITABILITY CRS (0.012 MG)

TRICLABENDAZOLE FOR SYSTEM SUITABILITY CRS (0.012 MG)

68786-66-3

DISCOVER
AGNUS CASTUS FRUIT DRY EXTRACT HRS (350 MG)

AGNUS CASTUS FRUIT DRY EXTRACT HRS (350 MG)

NA

DISCOVER
ERYTHROPOIETIN FOR PHYSICOCHEMICAL TESTS  CRS (16 MG)

ERYTHROPOIETIN FOR PHYSICOCHEMICAL TESTS CRS (16 MG)

NA

DISCOVER
SODIUM ALENDRONATE TRIHYDRATECRS (150 MG)

SODIUM ALENDRONATE TRIHYDRATECRS (150 MG)

121268-17-5

DISCOVER
ISOPROPYL ALCOHOL CRS (100 MG)

ISOPROPYL ALCOHOL CRS (100 MG)

67-63-0

DISCOVER
BUFEXAMAC IMPURITY A CRS (10 MG)

BUFEXAMAC IMPURITY A CRS (10 MG)

4547-57-3

DISCOVER
BUFEXAMAC IMPURITY B CRS (15 MG)

BUFEXAMAC IMPURITY B CRS (15 MG)

29056-06-2

DISCOVER
BUFEXAMAC IMPURITY C CRS (15 MG)

BUFEXAMAC IMPURITY C CRS (15 MG)

1185726-73-1

DISCOVER
BUFEXAMAC IMPURITY D CRS (10 MG)

BUFEXAMAC IMPURITY D CRS (10 MG)

3413-59-0

DISCOVER
PERMETHRIN (25:75) CRS (350 MG)

PERMETHRIN (25:75) CRS (350 MG)

52645-53-1

DISCOVER